Share
NEW YORK, Aug. 4, 2025 - OrbiMed, a leading global healthcare investment firm, today announced it has raised $1.86 billion in commitments for OrbiMed Royalty and Credit Opportunities Fund V.
Consistent with its predecessors, Fund V will provide tailored investment solutions to growth-oriented healthcare companies, with a focus on non-dilutive credit and royalty-based financing. OrbiMed expects to partner with healthcare companies across many sectors, including biopharmaceuticals, medical devices, diagnostics and technology-enabled healthcare services.
"Equity markets have been challenging in recent years for biotech and life sciences companies," said OrbiMed General Partner Matthew Rizzo. "Our flexible, non-dilutive capital solutions can help our portfolio companies to grow and thrive despite these volatile market conditions. The OrbiMed platform is uniquely positioned to fund healthcare innovation and growth on a global basis."
Investors in this new fund include a broad range of medical institutions, university endowments, foundations, pension funds, sovereign wealth funds and family offices.
"Over 90% of Fund V's committed capital is from existing, long-standing firm relationships," said OrbiMed Managing Partner Carter Neild. "We are grateful for this support, and will endeavor to deliver exceptional results to our partners."
About OrbiMed
OrbiMed is a leading healthcare investment firm, with over $17 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed's team of over 145 professionals is based in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya and other key global markets. For more information, please visit www.orbimed.com or follow us on X @OrbiMed.
Contact
Carter Neild, CFA
Phone: (212) 739.6400
Email: NeildC@OrbiMed.com
